Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCS) Total Debt (2022 - 2026)

HeartSciences' Total Debt history spans 4 years, with the latest figure at $421564.0 for Q1 2026.

  • For Q1 2026, Total Debt changed N/A year-over-year to $421564.0; the TTM value through Jan 2026 reached $421564.0, changed N/A, while the annual FY2023 figure was $500000.0, 88.74% down from the prior year.
  • Total Debt reached $421564.0 in Q1 2026 per HSCS's latest filing, up from $49470.0 in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $4.4 million in Q2 2022 to a low of $49470.0 in Q4 2024.
  • Average Total Debt over 4 years is $1.1 million, with a median of $500000.0 recorded in 2023.
  • Peak YoY movement for Total Debt: crashed 88.74% in 2023, then changed 0.0% in 2024.
  • A 4-year view of Total Debt shows it stood at $1.0 million in 2022, then crashed by 50.0% to $500000.0 in 2023, then plummeted by 90.11% to $49470.0 in 2024, then skyrocketed by 752.16% to $421564.0 in 2026.
  • Per Business Quant, the three most recent readings for HSCS's Total Debt are $421564.0 (Q1 2026), $49470.0 (Q4 2024), and $500000.0 (Q3 2024).